Difference between revisions of "Team:IISc Bangalore/Parts"

(Prototype team page)
 
 
(46 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{IISc_Bangalore}}
+
{{Template:IISc_Bangalore/hide}}
 +
{{Template:IISc_Bangalore/bootstrap.css}}
 +
{{Template:IISc_Bangalore/fontawesome.css}}
 +
{{Template:IISc_Bangalore/style.css}}
 +
{{Template:IISc_Bangalore/sidebar.css}}
 +
{{Template:IISc_Bangalore/safety.css}}
 +
{{Template:IISc_Bangalore/animate.css}}
 +
{{Template:IISc_Bangalore/hover.css}}
 +
{{Template:IISc Bagalore/collaborations.css}}
 +
{{Template:IISc_Bangalore/accordian.css}}
 +
{{Template:IISc_Bangalore/sidebar.js}}
 +
{{Template:IISc_Bangalore/anijs.js}}
 +
 
 
<html>
 
<html>
 +
<head>
 +
<title>Team IISc iGem</title>
  
 +
<link rel='stylesheet prefetch' href='http://netdna.bootstrapcdn.com/font-awesome/4.2.0/css/font-awesome.css'>
  
 +
<link rel="stylesheet" href="http://anijs.github.io/lib/anicollection/anicollection.css" />
  
 +
<meta name="viewport" content="width=device-width, initial-scale=1">
 +
  <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/css/bootstrap.min.css">
 +
  <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.12.4/jquery.min.js"></script>
 +
  <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js"></script>
  
 +
<link href="css/bootstrap.css" rel="stylesheet" type="text/css" media="all">
 +
<link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/css/bootstrap.min.css" integrity="sha384-BVYiiSIFeK1dGmJRAkycuHAHRg32OmUcww7on3RYdg4Va+PmSTsz/K68vbdEjh4u" crossorigin="anonymous">
 +
<script src="https://use.fontawesome.com/fce310c82d.js"></script>
  
 +
<script src="js/jquery-1.11.0.min.js"></script>
 +
<script type="text/javascript" src="js/bootstrap.js"></script>
  
<div class="column full_size">
+
<link href="css/style.css" rel="stylesheet" type="text/css" media="all"/>
 +
<link rel="stylesheet" href="css/flexslider.css" type="text/css" media="screen" />
  
 +
<meta name="viewport" content="width=device-width, initial-scale=1">
 +
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
 +
<script type="application/x-javascript"> addEventListener("load", function() { setTimeout(hideURLbar, 0); }, false); function hideURLbar(){ window.scrollTo(0,1); }>
 +
</script>
 +
<meta name="keywords" content="Team IISc igem" />
 +
<!--Google Fonts-->
 +
<link href="css/font-awesome.min.css" rel="stylesheet" type="text/css" media="all" />
 +
<link href='//fonts.googleapis.com/css?family=Roboto:400,700' rel='stylesheet' type='text/css'>
 +
<link href="https://fonts.googleapis.com/css?family=Bitter" rel="stylesheet">
 +
<link href="https://fonts.googleapis.com/css?family=Varela+Round" rel="stylesheet">
 +
<link href="https://fonts.googleapis.com/css?family=Roboto:300" rel="stylesheet">
 +
<link href="https://fonts.googleapis.com/css?family=Cormorant+Garamond:400,500" rel="stylesheet">
 +
<!--JS for animate-->
 +
<link href="css/animate.css" rel="stylesheet" type="text/css" media="all">
  
<p>Each team will make new parts during iGEM and will submit them to the Registry of Standard Biological Parts. The iGEM software provides an easy way to present the parts your team has created. The <code>&lt;groupparts&gt;</code> tag (see below) will generate a table with all of the parts that your team adds to your team sandbox.</p>
 
<p>Remember that the goal of proper part documentation is to describe and define a part, so that it can be used without needing to refer to the primary literature. Registry users in future years should be able to read your documentation and be able to use the part successfully. Also, you should provide proper references to acknowledge previous authors and to provide for users who wish to know more.</p>
 
  
 +
<!-- here are mine -->
 +
<link rel="stylesheet" href="sidebar.css">
 +
<link rel="stylesheet" href="notebSafety.css">
 +
<link rel="stylesheet" href="hover.css" >
 +
<script src="sidebar.js"></script>
 +
</head>
 +
<body>
 +
<!--banner start here-->
 +
<!-- <div class="banner">
 +
  <div class="container"> -->
 +
<nav class="navbar navbar-fixed-top text-center navbar-inverse">
 +
        <div class="container-fluid">
 +
        <div class="navbar-header">
 +
  </div>
 +
        <div class="collapse navbar-collapse" id="myNavbar">
 +
        <ul class="nav navbar-nav">
 +
          <li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore">Home</a></li>
 +
          <li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Team">Team</a></li>
  
</div>
 
  
 +
<li class="dropdown"><a class="dropdown-toggle" data-toggle="dropdown" href="#">Project </a>
 +
        <ul class="dropdown-menu">
 +
          <li><a href="https://2016.igem.org/Team:IISc_Bangalore/Description">Description</a></li>
 +
          <li><a href="https://2016.igem.org/Team:IISc_Bangalore/Experiments">Experiments</a></li>
 +
          <li><a href="https://2016.igem.org/Team:IISc_Bangalore/Results">Results</a></li>
 +
          <li><a href="https://2016.igem.org/Team:IISc_Bangalore/Notebook">Notebook</a></li>
 +
          <li><a href="https://2016.igem.org/Team:IISc_Bangalore/Safety">Safety</a></li>
 +
        </ul>
 +
      </li>
  
  
 +
<li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Parts">Parts</a></li>
  
 +
                <li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Collaborations">Collaborations</a></li>
 +
        <li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Attributions">Attributions</a></li>
 +
       
 +
<li class="dropdown"><a class="dropdown-toggle" data-toggle="dropdown" href="#">Human Practices</a>
 +
        <ul class="dropdown-menu">
 +
          <li><a href="https://2016.igem.org/Team:IISc_Bangalore/Human_Practices">Human Practices</a></li>
 +
          <li><a href="https://2016.igem.org/Team:IISc_Bangalore/HP/Silver">HP Silver</a></li>
 +
          <li><a href="https://2016.igem.org/Team:IISc_Bangalore/HP/Gold">HP Gold</a></li>
 +
        </ul>
 +
      </li>
  
<div class="column half_size">
+
        <li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/InterLab">InterLab</a></li>
<div class="highlight">
+
<li class="dropdown"><a class="dropdown-toggle" data-toggle="dropdown" href="#">Special Prizes</a>
<h5>Note</h5>
+
      <ul class="dropdown-menu">
<p>Note that parts must be documented on the <a href="http://parts.igem.org/Main_Page"> Registry</a>. This page serves to <i>showcase</i> the parts you have made. Future teams and other users and are much more likely to find parts by looking in the Registry than by looking at your team wiki.</p>
+
          <li><a href="https://2016.igem.org/Team:IISc_Bangalore/Integrated_Practices">Integrated Human Practices</a></li>
</div>
+
          <li><a href="https://2016.igem.org/Team:IISc_Bangalore/Engagement">Education and Public Engagement</a></li>
</div>
+
          <li class="active"><a href="https://2016.igem.org/Team:IISc_Bangalore/Model">Model</a></li>
 +
          <li><a href="https://2016.igem.org/Team:IISc_Bangalore/Measurement">Measurement</a></li>
 +
          <li><a href="https://2016.igem.org/Team:IISc_Bangalore/Entrepreneurship">Entrepreneurship</a></li>
 +
          <li><a href="https://2016.igem.org/Team:IISc_Bangalore/Design">Applied Design</a></li>
 +
        </ul>
 +
      </li>
 +
        </ul>
  
 +
      </div>
  
 +
      </div>
 +
      </nav>
  
  
<div class="column half_size">
+
<div class="banner-main">
  
<h5>Adding parts to the registry</h5>
+
  <section class="slider">
<p>You can add parts to the Registry at our <a href="http://parts.igem.org/Add_a_Part_to_the_Registry">Add a Part to the Registry</a> link.</p>
+
          <div class="flexslider">
<p>We encourage teams to start completing documentation for their parts on the Registry as soon as you have it available. The sooner you put up your parts, the better you will remember all the details about your parts. Remember, you don't need to send us the DNA sample before you create an entry for a part on the Registry. (However, you <b>do</b> need to send us the DNA sample before the Jamboree. If you don't send us a DNA sample of a part, that part will not be eligible for awards and medal criteria.)</p>
+
<span class="attri hvr-bounce-to-right ">Parts</html>
 +
[[File:IgemIISc.jpg|100px]]
 +
<html></span>
 +
 
 +
        </div>
 +
      </section>
 +
 
 +
</div>
 +
 
 +
<!--FlexSlider-->
 +
<link rel="stylesheet" href="css/flexslider.css" type="text/css" media="screen" />
 +
<script defer src="js/jquery.flexslider.js"></script>
 +
<script type="text/javascript">
 +
    $(function(){
 +
      SyntaxHighlighter.all();
 +
    });
 +
    $(window).load(function(){
 +
      $('.flexslider').flexslider({
 +
        animation: "slide",
 +
        start: function(slider){
 +
          $('body').removeClass('loading');
 +
        }
 +
      });
 +
    });
 +
  </script>
 +
</div>
 
</div>
 
</div>
 +
<!--banner end here-->
 +
<!--welcome-->
 +
<div id="welcome" class="welcome w3l">
 +
<div class="container">
  
 +
<div class="welcome-grids">
 +
<!-- <div class="row">
 +
<div class="col-md-12 welcome-grid wow slideInDown animated" data-wow-delay=".5s" onclick="openPerson1()" id="overv">
 +
<div class="wel1 hvr-hang">
 +
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
 +
<h4>Overview</h4>
 +
<p>With the advent of rDNA technology...</p>
 +
</div>
 +
</div>
 +
</div>
 +
<div class="row">
 +
<a href="#refer1"> <div class="col-md-4 welcome-grid animated wow slideInLeft animated animated" data-wow-duration="1200ms" data-wow-delay="500ms" >
 +
<div class="wel2 hvr-hang">
 +
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
 +
<h4>Basic</h4>
 +
<p>List of basic parts used ... </p>
 +
</div>
 +
</div>
 +
</a>
 +
<a href="#refer2"> <div class="col-md-4 welcome-grid wow slideInUp animated" data-wow-delay=".5s">
  
 +
<div class="wel3 hvr-hang">
 +
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
 +
<h4>Composite</h4>
 +
<p>List of composite parts used ... </p>
 +
</div>
 +
</div></a>
 +
<a href="#refer3" > <div class="col-md-4 welcome-grid wow slideInRight animated" data-wow-delay=".5s" >
  
 +
<div class="wel4 hvr-hang">
 +
<span class="glyphicon glyphicon-chevron-down" aria-hidden="true" ></span>
 +
<h4>Parts collection</h4>
 +
<p>Parts collection...</p>
 +
</div>
 +
</div> -->
 +
</a> <div class="clearfix"></div>
 +
</div>
 +
</div>
 +
</div>
 +
</div>
 +
<!--welcome-->
  
 +
<!--content-middle-->
 +
<div class="content-middle wthree">
 +
<div class="container" id="refer1">
 +
<div class="mid-content wow fadeInRight animated" data-wow-delay=".5s">
 +
<h3>Existing parts</h3>
  
<div class="column half_size">
+
</div>
 +
<div class="row">
 +
<div class="refer col-md-6">
 +
<h2>Basic</h2>
 +
<table class="table table-inverse">
 +
  <thead>
 +
    <tr>
 +
      <th>Name</th>
 +
      <th>Type</th>
 +
      <th>Designer</th>
 +
      <th>Length</th>
 +
    </tr>
 +
  </thead>
 +
  <tbody>
 +
    <tr>
 +
      <th scope="row"><a href="http://parts.igem.org/Part:BBa_R0040">BBa_R0040</a></th>
 +
      <td>pTet promoter</td>
 +
      <td>June Rhee, Connie Tao, Ty Thomson, Louis Waldman Group: Antiquity (2003-01-31)</td>
 +
      <td>54 bp</td>
 +
    </tr>
 +
   
 +
  </tbody>
 +
</table>
  
<h5>What information do I need to start putting my parts on the Registry?</h5>
 
<p>The information needed to initially create a part on the Registry is:</p>
 
<ul>
 
<li>Part Name</li>
 
<li>Part type</li>
 
<li>Creator</li>
 
<li>Sequence</li>
 
<li>Short Description (60 characters on what the DNA does)</li>
 
<li>Long Description (Longer description of what the DNA does)</li>
 
<li>Design considerations</li>
 
</ul>
 
  
 +
</div>
 +
</div>
 +
<div class="row">
 +
<div class="refer col-md-6">
 +
<h2>Composite</h2>
 +
<table class="table table-inverse">
 +
  <thead>
 +
    <tr>
 +
      <th>Name</th>
 +
      <th>Type</th>
 +
      <th>Designer</th>
 +
      <th>Length</th>
 +
    </tr>
 +
  </thead>
 +
  <tbody>
 +
    <tr>
 +
      <th scope="row"><a href="http://parts.igem.org/Part:BBa_R0040">BBa_K1352000</a></th>
 +
      <td>Ag43 under pBAD/araC promoter</td>
 +
      <td>June Rhee, Connie Tao, Ty Thomson, Louis Waldman Group: Antiquity (2003-01-31)</td>
 +
      <td>54 bp</td>
 +
    </tr>
 +
    <tr>
 +
      <th scope="row"><a href="http://parts.igem.org/Part:BBa_R0040">BBa_I746908</a></th>
 +
      <td>sfGFP under pBAD/araC promoter</td>
 +
      <td>Ana-Maria Cujba, Martyna Sroka  Group: iGEM14_Aberdeen_Scotland  (2014-10-01)</td>
 +
      <td>4493 bp</td>
 +
    </tr>
 +
    <tr>
 +
      <th scope="row"><a href="http://parts.igem.org/Part:BBa_R0040">BBa_K1072000 </a></th>
 +
      <td>Lux based quorum sensing system</td>
 +
      <td>Yichong wang, Rui chen, Xihao liao and Junjie zhang  Group: iGEM13_SCUT  (2013-08-31)</td>
 +
      <td>2910 bp</td>
 +
    </tr>
 +
    <tr>
 +
      <th scope="row"><a href="http://parts.igem.org/Part:BBa_R0040">BBa_K525998 </a></th>
 +
      <td>This part consists of a T7 bacteriophage promoter followed by a very strong RBS – BBa_B0034</td>
 +
      <td>Anna Drong  Group: iGEM11_Bielefeld-Germany  (2011-09-13)</td>
 +
      <td>32 bp</td>
 +
    </tr>
 +
   
 +
  </tbody>
 +
</table>
 +
<h2>Description</h2>
 
<p>
 
<p>
We encourage you to put up <em>much more</em> information as you gather it over the summer. If you have images, plots, characterization data and other information, please also put it up on the part page. </p>
+
<b>BBa_R0040</b>
 +
<p>This part was used as a negative control for fluorescence measurements, since it is non-coding except for chloramphenicol resistance.</p>
 +
<b>BBa_K1352000</b>
 +
<p>Ag43 under pBAD/araC promoter. This part codes with the Ag43 pro-protein under the control of the pBAD/araC regulation system.</p>
 +
<p>Briefly, Antigen 43 (Ag43) is a bacterial cell adhesion outer membrane protein, belonging to the auto-transporter family. It consists of two subunits – β, a trans-membrane β-barrel protein and α, a secretory protein that non-covalently binds to the β subunit and is responsible for the aggregation by forming α-α dimers. These two subunits come from the same peptide chain that is cleaved by an aspartate protease domain in the same pro-protein. Phenotypically, Ag43 expression leads to inter-cell aggregation.</p>
 +
We used BBa_K1352000 as PCR templates to make tagged variants of Ag43 (BBa_K2168000 and BBa_K2168001).
 +
For a excellent description of Ag43, we recommend visiting <Team:Aberdeen_Scotland’s description of Ag43>. <Please add hyperlink.>
 +
<b>BBa_I746908</b>
 +
<p>This part codes for sfGFP under regulation of pBAD/araC system.
 +
We used this part to characterize the pBAD/araC regulation system, more specifically promoter activity repression by glucose, since this had paradoxically not been checked in the past 12 years. For more details about experiments and results, please click <here>.</p>
 +
<b>BBa_K1072000</b>
 +
<p>Lux based quorum sensing system.</p>
 +
</html>
 +
[[File:AHL.png|400px|Schematic of quorum sensing system.]]
 +
<html>
 +
<p>Quorum sensing systems are biological regulation circuits that allow gene regulation dependent on local cell-densities. A well-studied example is that in Aliivibrio fischeri lux quorum sensing system.</p>
 +
<p>The system works as follows. luxI gene under the pLuxI promoter encodes for the LuxI AHL-synthetase enzyme that synthesizes AHL, non-polar signalling molecules that can diffuse out into the extracellular environment. Another protein encoded by this part, LuxR from the luxR gene under the pluxR promoter, binds to AHL and the LuxR-AHL complex homodimerizes further to give a (LuxR-AHL) dimer. This dimer acts as a transcriptional activator for the pluxI promoter, leading to a positive feedback loop for luxI-luxR expression and AHL synthesis.</p>
 +
<p>Further, the dimerization of the LuxR-AHL complex leads to a positive Hill coefficient for the process leading to a switch-like behaviour with respect to the AHL concentration. This lead to a switch like behaviour with respect to cell-density since the AHL production rate is dependent on the local cell density.</p>
 +
<p>Hence, any gene under the pluxI promoter would show a switching behaviour dependent on cell-density. We decided to check the same for BBa_K1072000, one for the few parts that has a complete quorum sensing system with a fluorescent reporter. So far, the characterization of this part has a microscopy image of green fluorescent cells; however, quorum sensing can established only by a growth curve. We have shown quorum sensing by this part experimentally. For experimental details, please click <here>.</p>
 +
<b>BBa_K525998</b>
 +
<p>This part consists of a T7 bacteriophage promoter followed by a very strong RBS – BBa_B0034. This part was chosen by us for collaborating with the <IIT Madras team> on their <measurement of transcriptional noise>. The activity of this promoter seems to be inconclusive</p>
  
</div>
+
</div>
 +
</div>
 +
</div>
 +
</div>
 +
<!--content-middle-->
 +
<hr>
 +
<!--content-middle-->
 +
<div class="content-middle wthree">
 +
<div class="container" id="refer2">
 +
<div class="mid-content wow fadeInRight animated" data-wow-delay=".5s">
 +
<h3>New parts</h3>
 +
</div>
 +
<div class="row">
 +
<div class="refer col-md-6">
 +
<table class="table table-inverse">
 +
  <thead>
 +
    <tr>
 +
      <th>Name</th>
 +
      <th>Type</th>
 +
      <th>Designer</th>
 +
      <th>Length</th>
 +
    </tr>
 +
  </thead>
 +
  <tbody>
 +
   
 +
    <tr>
 +
     
 +
      <th scope="row"><a href="http://parts.igem.org/Part:BBa_K1352000">BBa_K2168000 </a></th>
 +
      <td></td>
 +
      <td> Arunavo Chakraborty  Group: iGEM16_IISc_Bangalore  (2016-10-13)
 +
</td>
 +
      <td>4511 bp</td>
 +
    </tr>
 +
    <tr>
 +
     
 +
      <th scope="row"><a href="http://parts.igem.org/Part:BBa_I746908">BBa_K2168001</a></th>
 +
      <td></td>
 +
      <td>Arunavo Chakraborty  Group: iGEM16_IISc_Bangalore  (2016-10-13)</td>
 +
      <td>5258 bp</td>
 +
    </tr>
 +
   
 +
  </tbody>
 +
</table>
 +
<b>BBa_K2168000</b> 
 +
<p>This is a modification of BBa_K1352000, where Ag43 has been tagged on the N-terminal with a 6xHis tag for purification and quantification. This part was prepared by Gibson assembly, the details of which can be found <here>.
 +
The location of the 6xHis tag would be the most critical since the functioning of N-terminal signal peptide needs to be maintained for Ag43 to remain phenotypically active.</p>
 +
<b>BBa_K2168001</b>
 +
<p>This is a modification of BBa_K1352000, where Ag43 has been tagged at the N-terminal with 6xHis tag and at the C-terminal with a sfGFP tag. This part was prepared by Gibson assembly, the details of which can be found
 +
<a href="https://static.igem.org/mediawiki/2016/b/b2/IISc_Gibsons.pdf">here</a>.
 +
In addition to the location of the 6xHis tag, the linker between the Ag43 and the sfGFP coding sequences needs to be chosen with some thought. The linker that we choose as a (GGGGS)2 amino acid sequence, which would be a flexible linker with intermediate hydrophobicity.<br>
 +
However, there is a reasonable possibility of this part being non-functional since the C-terminal amino acid for Type V auto-transporter family (of which Ag43 is a member) seems to be critical for integration of the protein on the outer-membrane. Since the C-terminal of Ag43-sfGFP would no longer be free, issues with aggregation due to BBa_K2168001 were expected.<br>
 +
Experimentally, we found the over-expressed Ag43-sfGFP chimera to be present in cellular interior based on epifluorescence microscopy images of induced cells.</p>
  
  
<div class="column half_size">
+
</div>
 +
</div>
 +
</html>
 +
[[File:Db3.png|300px|Anti-His Dot blot to check His-tag in BBa_K2168000/8001. pTet -ve control.]]
 +
<html>
 +
</html>
 +
[[File:Db2.png|300px|Anti-His Dot blot to check His-tag in BBa_K2168000/8001. pTet -ve control.]]
 +
<html>
 +
</html>
 +
[[File:Ag43gfp.png|500px|Bacteria transformed with BBa_K2168001 showing fluorescence after induction by Arabinose.]]
 +
<html>
 +
</div>
 +
</div>
 +
<!--content-middle-->
 +
<!--content-middle-->
 +
<div class="content-middle wthree">
 +
<div class="container" id="refer2">
 +
<div class="mid-content wow fadeInRight animated" data-wow-delay=".5s">
 +
<h3>Parts collection</h3>
 +
</div>
 +
<div class="row">
 +
<div class="refer col-md-6">
 +
<p>Ag43 measurement systems</p>
 +
<table class="table table-inverse">
 +
  <thead>
 +
    <tr>
 +
      <th>Name</th>
 +
      <th>Type</th>
 +
      <th>Designer</th>
 +
      <th>Length</th>
 +
    </tr>
 +
  </thead>
 +
  <tbody>
 +
   
 +
    <tr>
 +
     
 +
      <th scope="row"><a href="http://parts.igem.org/Part:BBa_K1352000">BBa_K2168000 </a></th>
 +
      <td></td>
 +
      <td>Arunavo Chakraborty  Group: iGEM16_IISc_Bangalore  (2016-10-13)</td>
 +
      <td>4511 bp</td>
 +
    </tr>
 +
    <tr>
 +
     
 +
      <th scope="row"><a href="http://parts.igem.org/Part:BBa_I746908">BBa_K2168001 </a></th>
 +
      <td></td>
 +
      <td>sfGFP under pBAD/ara promoter</td>
 +
      <td> Arunavo Chakraborty  Group: iGEM16_IISc_Bangalore  (2016-10-13)</td>
 +
      <td>5258 bp</td>
 +
    </tr>
 +
   
 +
  </tbody>
 +
</table>
 +
The parts are Ag43 chimeras with reporters to quantify Ag43 concentration. BBa_K2168001 has both a fluorescent tag and a 6xHis tag to independently estimate the concentration of Ag43 and check the agreement of both methods, whereas BBa_K2168000 has only a 6xHis tag, in case the fluorescent tag interferes with aggregation due to Ag43 in BBa_K2168001. The common theme is to estimate Ag43 concentration and correlate it with the degree of aggregation, thus determining the feasibility of replacing or supplementing centrifugation with Ag43 aggregation.
  
<h5>Inspiration</h5>
+
</div>
<p>We have a created  a <a href="http://parts.igem.org/Well_Documented_Parts">collection of well documented parts</a> that can help you get started.</p>
+
</div>
 +
</div>
 +
</div>
 +
<!--content-middle-->
  
<p> You can also take a look at how other teams have documented their parts in their wiki:</p>
+
<hr>
<ul>
+
<!--content-middle-->
<li><a href="https://2014.igem.org/Team:MIT/Parts"> 2014 MIT </a></li>
+
<div class="content-middle wthree">
<li><a href="https://2014.igem.org/Team:Heidelberg/Parts"> 2014 Heidelberg</a></li>
+
<div class="container" id="refer3">
<li><a href="https://2014.igem.org/Team:Tokyo_Tech/Parts">2014 Tokyo Tech</a></li>
+
<div class="mid-content wow fadeInRight animated" data-wow-delay=".5s">
</ul>
+
<h3>Planned parts</h3>
</div>
+
</div>
 
+
<div class="row">
<div class="column full_size">
+
<div class="refer col-md-6">
<h5>Part Table </h5>
+
<h3>Native lux system:</h3>
<div class="highlight">
+
Given our interest in protein-over-expression, we designed a quorum sensing system to allow for greater protein-over-expression without leaky expression.
 +
For this, we hypothesized that have bicistronic expression system for luxI and GFP, since it decreases the competition for LuxR-AHL dimer by the pluxI.
 +
So, we ordered the native lux system codon optimized for E coli from IDT, however, we received empty tubes from them. <gel image attached>
  
  
 +
</div>
 +
</div>
 
</html>
 
</html>
<groupparts>iGEM2016 Example</groupparts>
+
[[File:IDT IISc gel.jpeg|400px]]
 
<html>
 
<html>
</div>
+
</div>
</div>
+
</div>
 +
 
 +
<!--content-middle-->
 +
<!--events
 +
 
 +
events-->
 +
 
 +
<div id="person1Tab" class="person1Tab">
 +
 
 +
  <div class="row">
 +
    <div class="trans col-md-12">
 +
 
 +
    </div>
 +
  </div>
 +
  <div class="row">
 +
    <div class="col-md-6 person1Tabcontent">
 +
      <a href="javascript:void(0)" class="closebtn" onclick="closeTab()">&times;</a>
 +
      <h1>Overview</h1>
 +
      <p class="whitef">With the advent of rDNA technology in the late 1970s, medicine, agriculture and several other areas underwent a quantum leap and from that point, progress only hastened, from one only one recombinant pharmaceutical  approved for human use (insulin) in 1982 to one hundred and fifty-one FDA approved protein based recombinant pharmaceuticals by 2009<a href="#refer">[1]</a>.
 +
Despite being in high demand (due to the fact that most recombinant products produced on an industrial scale are therapies for chronic diseases like cancer and diabetes), recombinant products are expensive due to several factors like long and expensive development time, high failure rate (~80%) of the products developed, manufacturing costs requiring expensive technologies and processes (bioreactors, column chromatography, sterile conditions, etc) and the involvement of skilled labor on both the manufacturing and the healthcare provider’s side<a href="#refer">[2]</a>. Treatments with these pharmaceuticals can cost from around 10,000 to 100,000 € per year for a single patient[2]. As scientists and engineers, it seems obvious that our contribution can be most easily and effectively be made at the level of manufacturing costs; to try to bring down the cost of these life-saving products.
 +
      <br><span class="readm hvr-ripple-out">Read more</span>
 +
</p>
 +
    </div>
 +
      </div>
 +
    </div>
 +
 
 +
<div id="person2Tab" class="person2Tab">
 +
 
 +
  <div class="row">
 +
    <div class="trans col-md-12">
 +
 
 +
    </div>
 +
  </div>
 +
  <div class="row">
 +
    <div class="col-md-6 person2Tabcontent">
 +
      <a href="javascript:void(0)" class="closebtn" onclick="closeTab()">&times;</a>
 +
      <h1>Basic</h1>
 +
      <p class="whitef">basic
 +
      <br><span class="readm hvr-ripple-out">Read more</span>
 +
</p>
 +
    </div>
 +
      </div>
 +
    </div>
 +
 
 +
<div id="person3Tab" class="person3Tab">
 +
 
 +
  <div class="row">
 +
    <div class="trans col-md-12">
 +
 
 +
    </div>
 +
  </div>
 +
  <div class="row">
 +
    <div class="col-md-6 person3Tabcontent">
 +
      <a href="javascript:void(0)" class="closebtn" onclick="closeTab()">&times;</a>
 +
      <h1>Composite</h1>
 +
      <p class="whitef">Composite
 +
      <br><span class="readm hvr-ripple-out">Read more</span>
 +
</p>
 +
    </div>
 +
      </div>
 +
    </div>
 +
 
 +
 
 +
<div id="person4Tab" class="person4Tab">
 +
 
 +
  <div class="row">
 +
    <div class="trans col-md-12">
 +
 
 +
    </div>
 +
  </div>
 +
  <div class="row">
 +
    <div class="col-md-6 person4Tabcontent">
 +
      <a href="javascript:void(0)" class="closebtn" onclick="closeTab()">&times;</a>
 +
      <h1>Collection</h1>
 +
      <p class="whitef">Collection
 +
      <br><span class="readm hvr-ripple-out">Read more</span>
 +
</p>
 +
 
 +
    </div>
 +
      </div>
 +
    </div>
 +
 
 +
 
  
 +
<!--footer-->
 +
<div class="footer">
 +
<div class="container">
 +
<div class="footer-grids">
 +
<!-- <div class="col-md-4 footer-grid wow fadeInUp animated" data-wow-delay=".5s">
 +
<h3>About Cellfiefuge</h3>
 +
<p>From IISc.</p>
 +
</div> -->
  
 +
<div class="col-md-4 footer-grid animated wow fadeInDown animated animated" data-wow-duration="1200ms" data-wow-delay="500ms">
 +
<h3>Sponsors</h3><br><br>
 +
<ul>
 +
<li>
 +
</html>
 +
[[File:Snapgeneiisc.png|200px]]
 +
<html>
 +
</li><br>
 +
<li></html>
 +
[[File:Wellcomedbtiisc.jpg|200px]]
 +
<html></li>
 +
<br>
 +
<li></html>
 +
[[File:Ibeciisc.png|100px]]
 +
<html></li>
 +
                                               
 +
                                       
 +
</ul>
 +
</div>
 +
                                <div class="col-md-4 footer-grid animated wow fadeInDown animated animated" data-wow-duration="1200ms" data-wow-delay="500ms">
 +
 +
<ul>
 +
<li>
 +
</html>
 +
[[File:Iisclogowhite.png|200px]]
 +
<html>
 +
</li><br>
 +
<li></html>
 +
[[File:Karnatakaiisc.png|100px]]
 +
<html></li>
 +
 +
                                               
 +
                                        <br>
 +
<li></html>
 +
[[File:Phdcareersupport.jpg|150px]]
 +
<html></li>
 +
</ul>
 +
</div>
 +
<div class="col-md-4 footer-grid animated wow fadeInUp animated animated" data-wow-duration="1200ms" data-wow-delay="500ms">
 +
<h3>Social</h3>
 +
<ul class="social-icons1">
 +
<li><a href="https://www.facebook.com/iiscbangaloreigem/?fref=ts" target="_blank"><i class="fa fa-facebook hvr-buzz"></i></a></li>
 +
<li><a href="https://twitter.com/IISc_iGEM" target="_blank"><i class="fa fa-twitter hvr-buzz"></i></a></li>
 +
</ul>
 +
</div>
  
 +
<div class="clearfix"> </div>
 +
</div>
  
 +
</div>
 +
</div>
 +
<!--footer-->
 +
<script src="http://anijs.github.io/lib/anijs/anijs.js"></script>
 +
<script src="http://anijs.github.io/lib/anijs/helpers/dom/anijs-helper-dom.js"></script>
 +
</body>
 
</html>
 
</html>

Latest revision as of 03:21, 20 October 2016

Team IISc iGem

Existing parts

Basic

Name Type Designer Length
BBa_R0040 pTet promoter June Rhee, Connie Tao, Ty Thomson, Louis Waldman Group: Antiquity (2003-01-31) 54 bp

Composite

Name Type Designer Length
BBa_K1352000 Ag43 under pBAD/araC promoter June Rhee, Connie Tao, Ty Thomson, Louis Waldman Group: Antiquity (2003-01-31) 54 bp
BBa_I746908 sfGFP under pBAD/araC promoter Ana-Maria Cujba, Martyna Sroka Group: iGEM14_Aberdeen_Scotland (2014-10-01) 4493 bp
BBa_K1072000 Lux based quorum sensing system Yichong wang, Rui chen, Xihao liao and Junjie zhang Group: iGEM13_SCUT (2013-08-31) 2910 bp
BBa_K525998 This part consists of a T7 bacteriophage promoter followed by a very strong RBS – BBa_B0034 Anna Drong Group: iGEM11_Bielefeld-Germany (2011-09-13) 32 bp

Description

BBa_R0040

This part was used as a negative control for fluorescence measurements, since it is non-coding except for chloramphenicol resistance.

BBa_K1352000

Ag43 under pBAD/araC promoter. This part codes with the Ag43 pro-protein under the control of the pBAD/araC regulation system.

Briefly, Antigen 43 (Ag43) is a bacterial cell adhesion outer membrane protein, belonging to the auto-transporter family. It consists of two subunits – β, a trans-membrane β-barrel protein and α, a secretory protein that non-covalently binds to the β subunit and is responsible for the aggregation by forming α-α dimers. These two subunits come from the same peptide chain that is cleaved by an aspartate protease domain in the same pro-protein. Phenotypically, Ag43 expression leads to inter-cell aggregation.

We used BBa_K1352000 as PCR templates to make tagged variants of Ag43 (BBa_K2168000 and BBa_K2168001). For a excellent description of Ag43, we recommend visiting . BBa_I746908

This part codes for sfGFP under regulation of pBAD/araC system. We used this part to characterize the pBAD/araC regulation system, more specifically promoter activity repression by glucose, since this had paradoxically not been checked in the past 12 years. For more details about experiments and results, please click .

BBa_K1072000

Lux based quorum sensing system.

Schematic of quorum sensing system.

Quorum sensing systems are biological regulation circuits that allow gene regulation dependent on local cell-densities. A well-studied example is that in Aliivibrio fischeri lux quorum sensing system.

The system works as follows. luxI gene under the pLuxI promoter encodes for the LuxI AHL-synthetase enzyme that synthesizes AHL, non-polar signalling molecules that can diffuse out into the extracellular environment. Another protein encoded by this part, LuxR from the luxR gene under the pluxR promoter, binds to AHL and the LuxR-AHL complex homodimerizes further to give a (LuxR-AHL) dimer. This dimer acts as a transcriptional activator for the pluxI promoter, leading to a positive feedback loop for luxI-luxR expression and AHL synthesis.

Further, the dimerization of the LuxR-AHL complex leads to a positive Hill coefficient for the process leading to a switch-like behaviour with respect to the AHL concentration. This lead to a switch like behaviour with respect to cell-density since the AHL production rate is dependent on the local cell density.

Hence, any gene under the pluxI promoter would show a switching behaviour dependent on cell-density. We decided to check the same for BBa_K1072000, one for the few parts that has a complete quorum sensing system with a fluorescent reporter. So far, the characterization of this part has a microscopy image of green fluorescent cells; however, quorum sensing can established only by a growth curve. We have shown quorum sensing by this part experimentally. For experimental details, please click .

BBa_K525998

This part consists of a T7 bacteriophage promoter followed by a very strong RBS – BBa_B0034. This part was chosen by us for collaborating with the on their . The activity of this promoter seems to be inconclusive


New parts

Name Type Designer Length
BBa_K2168000 Arunavo Chakraborty Group: iGEM16_IISc_Bangalore (2016-10-13) 4511 bp
BBa_K2168001 Arunavo Chakraborty Group: iGEM16_IISc_Bangalore (2016-10-13) 5258 bp
BBa_K2168000

This is a modification of BBa_K1352000, where Ag43 has been tagged on the N-terminal with a 6xHis tag for purification and quantification. This part was prepared by Gibson assembly, the details of which can be found . The location of the 6xHis tag would be the most critical since the functioning of N-terminal signal peptide needs to be maintained for Ag43 to remain phenotypically active.

BBa_K2168001

This is a modification of BBa_K1352000, where Ag43 has been tagged at the N-terminal with 6xHis tag and at the C-terminal with a sfGFP tag. This part was prepared by Gibson assembly, the details of which can be found here. In addition to the location of the 6xHis tag, the linker between the Ag43 and the sfGFP coding sequences needs to be chosen with some thought. The linker that we choose as a (GGGGS)2 amino acid sequence, which would be a flexible linker with intermediate hydrophobicity.
However, there is a reasonable possibility of this part being non-functional since the C-terminal amino acid for Type V auto-transporter family (of which Ag43 is a member) seems to be critical for integration of the protein on the outer-membrane. Since the C-terminal of Ag43-sfGFP would no longer be free, issues with aggregation due to BBa_K2168001 were expected.
Experimentally, we found the over-expressed Ag43-sfGFP chimera to be present in cellular interior based on epifluorescence microscopy images of induced cells.

Anti-His Dot blot to check His-tag in BBa_K2168000/8001. pTet -ve control. Anti-His Dot blot to check His-tag in BBa_K2168000/8001. pTet -ve control. Bacteria transformed with BBa_K2168001 showing fluorescence after induction by Arabinose.

Parts collection

Ag43 measurement systems

Name Type Designer Length
BBa_K2168000 Arunavo Chakraborty Group: iGEM16_IISc_Bangalore (2016-10-13) 4511 bp
BBa_K2168001 sfGFP under pBAD/ara promoter Arunavo Chakraborty Group: iGEM16_IISc_Bangalore (2016-10-13) 5258 bp
The parts are Ag43 chimeras with reporters to quantify Ag43 concentration. BBa_K2168001 has both a fluorescent tag and a 6xHis tag to independently estimate the concentration of Ag43 and check the agreement of both methods, whereas BBa_K2168000 has only a 6xHis tag, in case the fluorescent tag interferes with aggregation due to Ag43 in BBa_K2168001. The common theme is to estimate Ag43 concentration and correlate it with the degree of aggregation, thus determining the feasibility of replacing or supplementing centrifugation with Ag43 aggregation.

Planned parts

Native lux system:

Given our interest in protein-over-expression, we designed a quorum sensing system to allow for greater protein-over-expression without leaky expression. For this, we hypothesized that have bicistronic expression system for luxI and GFP, since it decreases the competition for LuxR-AHL dimer by the pluxI. So, we ordered the native lux system codon optimized for E coli from IDT, however, we received empty tubes from them.
IDT IISc gel.jpeg
×

Overview

With the advent of rDNA technology in the late 1970s, medicine, agriculture and several other areas underwent a quantum leap and from that point, progress only hastened, from one only one recombinant pharmaceutical approved for human use (insulin) in 1982 to one hundred and fifty-one FDA approved protein based recombinant pharmaceuticals by 2009[1]. Despite being in high demand (due to the fact that most recombinant products produced on an industrial scale are therapies for chronic diseases like cancer and diabetes), recombinant products are expensive due to several factors like long and expensive development time, high failure rate (~80%) of the products developed, manufacturing costs requiring expensive technologies and processes (bioreactors, column chromatography, sterile conditions, etc) and the involvement of skilled labor on both the manufacturing and the healthcare provider’s side[2]. Treatments with these pharmaceuticals can cost from around 10,000 to 100,000 € per year for a single patient[2]. As scientists and engineers, it seems obvious that our contribution can be most easily and effectively be made at the level of manufacturing costs; to try to bring down the cost of these life-saving products.
Read more

×

Basic

basic
Read more

×

Composite

Composite
Read more

×

Collection

Collection
Read more